Scott I. Raskin, DO
- Pediatric Neuro-Oncologist, Division of Oncology
- Assistant Professor, UC Department of Pediatrics
- scott.raskin@cchmc.org
- Board Certified
About
Biography
As a pediatric neuro-oncologist, my philosophy is to treat my patients' diseases to the best of my ability and care for them and their families as people, not just a condition to cure. Making sure we are here for families and patients as a whole ensures we’re providing the best possible care.
Initially, I was inspired to become a pediatrician because of my childhood pediatrician's care and experience. As I continued through medical training, I was amazed by children's resiliency and knew I wanted to care for them.
I was drawn to pediatric oncology because it uses the most current advances in healthcare. I also enjoy working with the most remarkable patients and families. Their strength inspires me to work harder every day.
In my research, I am trying to better understand how we can cure pediatric central nervous system (CNS) tumors with poor outcomes. I’m also looking at how to treat relapsed or refractory disease using novel clinical trials or therapies and directly translating this research from the lab.
In my free time, I like to explore parks and spend time outside with my family.
Certifications: Pediatrics, 2016; Pediatric Hematology / Oncology, 2021
Interests
Pediatric neuro-oncology; immunotherapy
Services and Specialties
Interests
Immunotherapy; developmental therapeutics; clinical trials
Research Areas
Locations (2)
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
The first described report of a patient with CHD7-associated CHARGE syndrome and a spinal schwannoma with a SH3PXD2A::HTRA1 fusion; a case report and review of literature. Neuro-Oncology Pediatrics. 2026; 2(2):wuag034.
MEK inhibitor-induced dropped head syndrome in pediatrics. Neuro-Oncology Pediatrics. 2026; 2(2):wuag024.
An analysis of PD1 pathway activity in malignant pediatric central nervous system tumors: a pediatric brain tumor consortium study, PBTC-N13. Neuro-Oncology Pediatrics. 2026; 2(2):wuag020.
DNMT3A R882C variant in a patient with a presumed pineal gland tumor, highlighting potential tumor susceptibility in Tatton-Brown-Rahman syndrome. Cancer Genetics. 2026; 302-303:162-165.
Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma. Neuro-Oncology. 2026; 28(2):535-551.
Overview of the neurotrophic tyrosine receptor kinase signaling pathway and therapeutic applications to brain tumors. In: Handbook of Brain Tumor Chemotherapy Molecular Therapeutics and Immunotherapy. 2026:501-513.
Chapter 29 Overview of the neurotrophic tyrosine receptor kinase signaling pathway and therapeutic applications to brain tumors. In: Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Elsevier; 2026:501-513.
Predictive capacity of mismatch repair status in the use of immune checkpoint inhibitors for the treatment of aggressive pituitary tumors and pituitary carcinomas: An illustrative case report and literature review. Surgical Neurology International. 2026; 17:252.
Disseminated pediatric low-grade glioma and hydrocephalus: a multinational consortium analysis of incidence and mortality. Journal of Neurosurgery: Pediatrics. 2025; 37(2):133-146.
IMMU-79. An Updated Analysis of PD1 and Immune Pathway Activity in Malignant Pediatric Central Nervous System (CNS) Tumors: A Pediatric Brain Tumor Consortium (PBTC) Study, PBTC-N13. Neuro-Oncology. 2025; 27(Supplement_5):v221-v221.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 2026 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey